Skip to content

Evaluation of Rate of Progression With Perimetry in Newly Diagnosed Open Angle Glaucoma

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02379208
Enrollment
60
Registered
2015-03-04
Start date
2015-04-30
Completion date
2020-05-31
Last updated
2015-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle, Ocular Hypertension

Keywords

Visual Field Tests, Ocular Hypertension, Glaucoma, Open-Angle, Quality of Life, Glaucoma progression, Early glaucoma, Frequency Doubling Technology (FDT), RareBit, Octopus 900 perimetry

Brief summary

The purpose of this study is to evaluate rate of progression in newly diagnosed open angle glaucoma with different types of perimetry. Would it be possible to find the rapidly progressing individuals sooner by doing perimetry more often? Is there a difference between different types of perimetry in early glaucoma? What would be the optimal timing of perimetry in newly diagnosed glaucoma? In addition the quality of life in glaucoma patients will be evaluated with two types of questionnaires in three different time points. The enrolled patients will receive appropriate treatment according to glaucoma management guidelines.

Interventions

None listed

Sponsors

Turku University Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recently diagnosed open angle glaucoma

Exclusion criteria

* Significant visual impairment due to another disease (e.g. diabetic retinopathy or maculopathy, cataract, visual field defect after stroke) * Inability to perform perimetry reliably

Design outcomes

Primary

MeasureTime frame
Change in mean defect in Octopus perimetryBaseline, 2, 4, 8, 12, 16, 20, 22, 24 months

Secondary

MeasureTime frameDescription
Change in VF-7- instrument score2, 12, 24 monthsChange in quality of life
Change in 15D-instrument score2, 12, 24 monthsChange in quality of life
Differences in visual field defects between Octopus, frequency doubling technology, RareBit-perimeters2, 12, 24 months

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026